Publications

1. Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, Boeve BF, Jones DT, Botha H, Ramanan VK, Knopman DS, Savica R, Josephs KA, Cliatt-Brown C, Andersen E, Day GS, Graff-Radford NR, Ertekin-Taner N, Lachner C, Wicklund M, van Harten A, Woodruff BK, Caselli RJ, Graff-Radford J. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. Mayo Clin Proc. 2024 Aug; 99 (8):1284-1296 Epub 2024 June 25
   View PubMed
2. Chen Y, Su Y, Wu J, Chen K, Atri A, Caselli RJ, Reiman EM, Wang Y, for the Alzheimer's Disease Neuroimaging Initiative. Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques. J Alzheimers Dis. 2024; 98 (4):1415-1426
   View PubMed
3. Bergamino M, Burke A, Sabbagh MN, Caselli RJ, Baxter LC, Stokes AM. Altered resting-state functional connectivity and dynamic network properties in cognitive impairment: an independent component and dominant-coactivation pattern analyses study. Front Aging Neurosci. 2024; 16:1362613 Epub 2024 Mar 18
   View PubMed
4. Prabhakaran D, Grant C, Pedraza O, Caselli R, Athreya AP, Chandler M. Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment. J Alzheimers Dis. 2024; 98 (1):83-94
   View PubMed
5. Yang Z, Su Y, Rouhi R, Farazi M, Zhu W, Chen Y, Reiman EM, Caselli RJ, Chen K, Wang Y, Lepore N. Pre-training graph attention convolution for brain structural imaging biomarker analysis and its application to Alzheimer's disease pathology identification. Proceedings - International Symposium on Biomedical Imaging. 2024; 10635797
   
6. Dong Q, Li Z, Liu W, Chen K, Su Y, Wu J, Caselli RJ, Reiman EM, Wang Y, Shen J. Correlation studies of Hippocampal Morphometry and Plasma NFL Levels in Cognitively Unimpaired Subjects. IEEE Trans Comput Soc Syst. 2023 Dec; 10 (6):3602-3608 Epub 2023 Nov 06
   View PubMed
7. Baxter LC, Limback-Stokin M, Patten KJ, Arreola AC, Locke DEC, Hu L, Zhou Y, Caselli RJ. Hippocampal connectivity and memory decline in cognitively intact APOE epsilon4 carriers. Alzheimers Dement. 2023 Sep; 19 (9):3806-3814 Epub 2023 Mar 12
   View PubMed
8. Beach TG, Sue LI, Scott S, Intorcia AJ, Walker JE, Arce RA, Glass MJ, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Stewart A, Martinez KN, Krupp A, McHattie R, Mariner M, Lorenzini I, Kuramoto A, Long KE, Tremblay C, Caselli RJ, Woodruff BK, Rapscak SZ, Belden CM, Goldfarb D, Choudhury P, Driver-Dunckley ED, Mehta SH, Sabbagh MN, Shill HA, Atri A, Adler CH, Serrano GE. Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy. J Neuropathol Exp Neurol. 2023 May 25; 82 (6):457-466
   View PubMed
9. Malek-Ahmadi M, Su Y, Ghisays V, Luo J, Devadas V, Chen Y, Lee W, Protas H, Chen K, Zetterberg H, Blennow K, Caselli RJ, Reiman EM. Plasma NfL is associated with the APOE epsilon4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults. Alzheimers Res Ther. 2023 Apr 10; 15 (1):74
   View PubMed
10. Wu J, Su Y, Zhu W, Jalili Mallak N, Lepore N, Reiman EM, Caselli RJ, Thompson PM, Chen K, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Improved Prediction of Amyloid-beta and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding. J Alzheimers Dis. 2023; 91 (2):637-651
    View PubMed
11. Wu J, Su Y, Chen Y, Zhu W, Reiman EM, Caselli RJ, Chen K, Thompson PM, Wang J, Wang Y, Alzheimer's Disease Neuroimaging Initiative. A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry. J Alzheimers Dis. 2023; 93 (3):1153-1168
    View PubMed
12. Caselli RJ, Chen Y, Chen K, Bauer RJ, Locke DEC, Woodruff BK. Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study. J Alzheimers Dis. 2023; 91 (3):1049-1058
    View PubMed
13. Cho HJ, Schulz P, Venkataraman L, Caselli RJ, Sierks MR. Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer's Disease. Int J Mol Sci. 2022 Dec 10; 23 (24)
    View PubMed
14. Yu F, Han SY, Salisbury D, Pruzin JJ, Geda Y, Caselli RJ, Li D. Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer's disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer's dementia. Pilot Feasibility Stud. 2022 Dec 2; 8 (1):243 Epub 2022 Dec 02
    View PubMed
15. Bergamino M, Burke A, Baxter LC, Caselli RJ, Sabbagh MN, Talboom JS, Huentelman MJ, Stokes AM. Longitudinal Assessment of Intravoxel Incoherent Motion Diffusion-Weighted MRI Metrics in Cognitive Decline. J Magn Reson Imaging. 2022 Dec; 56 (6):1845-1862 Epub 2022 Mar 23
    View PubMed
16. Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D, Montine TJ, Berry GJ, Reiman EM, Roltgen K, Boyd SD, Pinsky BA, Zehnder JL, Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J Neuropathol Exp Neurol. 2022 Aug 16; 81 (9):666-695
    View PubMed
17. Wu J, Su Y, Reiman EM, Caselli RJ, Chen K, Thompson PM, Wang J, Wang Y. Investigating the effect of Tau deposition and Apoe on hippocampal morphometry in Alzheimer's disease: a federated Chow test model. Proceedings - International Symposium on Biomedical Imaging. 2022 Mar; 2022
    
18. Wu J, Su Y, Reiman EM, Caselli RJ, Chen K, Thompson PM, Wang J, Wang Y. INVESTIGATING THE EFFECT OF TAU DEPOSITION AND APOE ON HIPPOCAMPAL MORPHOMETRY IN ALZHEIMER'S DISEASE: A FEDERATED CHOW TEST MODEL. Proc IEEE Int Symp Biomed Imaging. 2022 Mar; 2022 Epub 2022 Apr 26
    View PubMed
19. Wang G, Zhou W, Kong D, Qu Z, Ba M, Hao J, Yao T, Dong Q, Su Y, Reiman EM, Caselli RJ, Chen K, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Studying APOE varepsilon4 Allele Dose Effects with a Univariate Morphometry Biomarker. J Alzheimers Dis. 2022; 85 (3):1233-1250
    View PubMed
20. Wu J, Zhu W, Su Y, Gui J, Lepore N, Reiman EM, Caselli RJ, Thompson PM, Chen K, Wang Y. Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy. Proc SPIE Int Soc Opt Eng. 2021 Nov; 12088 Epub 2021 Dec 10
    View PubMed
21. Zhang J, Wu J, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y. Multi-Resemblance Multi-Target Low-Rank Coding for Prediction of Cognitive Decline With Longitudinal Brain Images. IEEE Trans Med Imaging. 2021 Aug; 40 (8):2030-2041 Epub 2021 July 30
    View PubMed
22. Zhang J, Dong Q, Shi J, Li Q, Stonnington CM, Gutman BA, Chen K, Reiman EM, Caselli RJ, Thompson PM, Ye J, Wang Y. Predicting future cognitive decline with hyperbolic stochastic coding. Med Image Anal. 2021 May; 70:102009 Epub 2021 Feb 24
    View PubMed
23. Wu J, Dong Q, Zhang J, Su Y, Wu T, Caselli RJ, Reiman EM, Ye J, Lepore N, Chen K, Thompson PM, Wang Y. Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology. Front Neurosci. 2021; 15:762458 Epub 2021 Nov 25
    View PubMed
24. Wang G, Dong Q, Wu J, Su Y, Chen K, Su Q, Zhang X, Hao J, Yao T, Liu L, Zhang C, Caselli RJ, Reiman EM, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition. Med Image Anal. 2021 Jan; 67:101877 Epub 2020 Oct 21
    View PubMed
25. Henderson AR, Wang Q, Meechoovet B, Siniard AL, Naymik M, De Both M, Huentelman MJ, Caselli RJ, Driver-Dunckley E, Dunckley T. DNA Methylation and Expression Profiles of Whole Blood in Parkinson's Disease. Front Genet. 2021; 12:640266 Epub 2021 Apr 26
    View PubMed
26. Wu J, Dong Q, Gui J, Zhang J, Su Y, Chen K, Thompson PM, Caselli RJ, Reiman EM, Ye J, Wang Y. Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases. Front Neurosci. 2021; 15:669595 Epub 2021 Aug 06
    View PubMed
27. Stonnington CM, Wu J, Zhang J, Shi J, Bauer Iii RJ, Devadas V, Su Y, Locke DEC, Reiman EM, Caselli RJ, Chen K, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding. J Alzheimers Dis. 2021; 81 (1):209-220
    View PubMed
28. Edlund AK, Chen K, Lee W, Protas H, Su Y, Reiman E, Caselli R, Nielsen HM. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers. J Alzheimers Dis. 2021; 81 (1):339-354
    View PubMed
29. Wu J, Chen Y, Wang P, Caselli RJ, Thompson PM, Wang J, Wang Y. Integrating Transcriptomics, Genomics, and Imaging in Alzheimer's Disease: A Federated Model. Front Radiol. 2021; 1:777030 Epub 2022 Jan 21
    View PubMed
30. Bergamino M, Nespodzany A, Baxter LC, Burke A, Caselli RJ, Sabbagh MN, Walsh RR, Stokes AM. Preliminary Assessment of Intravoxel Incoherent Motion Diffusion-Weighted MRI (IVIM-DWI) Metrics in Alzheimer's Disease. J Magn Reson Imaging. 2020 Dec; 52 (6):1811-1826 Epub 2020 July 04
    View PubMed
31. Caselli RJ, Knopman DS, Bu G. An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis. Alzheimers Dement. 2020 Nov; 16 (11):1582-1590 Epub 2020 June 26
    View PubMed
32. Tu Y, Mi L, Zhang W, Zhang H, Zhang J, Fan Y, Goradia D, Chen K, Caselli RJ, Reiman EM, Gu X, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Computing Univariate Neurodegenerative Biomarkers with Volumetric Optimal Transportation: A Pilot Study. Neuroinformatics. 2020 Oct; 18 (4):531-548
    View PubMed
33. Yin J, Reiman EM, Beach TG, Serrano GE, Sabbagh MN, Nielsen M, Caselli RJ, Shi J. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020 Jun 9; 94 (23):e2404-e2411 Epub 2020 May 26
    View PubMed
34. Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020 May; 581 (7806):71-76 Epub 2020 Apr 29
    View PubMed
35. Ghisays V, Goradia DD, Protas H, Bauer RJ 3rd, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Caselli RJ, Su Y, Chen K, Reiman EM. Brain imaging measurements of fibrillar amyloid-beta burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE epsilon4 allele. Alzheimers Dement. 2020 Apr; 16 (4):598-609 Epub 2020 Jan 16
    View PubMed
36. Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DEC, Woodruff BK, Reiman EM. Neuropsychological decline up to 20 years before incident mild cognitive impairment. Alzheimers Dement. 2020 Mar; 16 (3):512-523 Epub 2020 Jan 06
    View PubMed
37. Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR, Alzheimer's Disease Genetics Consortium. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 Feb 3; 11 (1):667 Epub 2020 Feb 03
    View PubMed
38. Beach TG, Adler CH, Zhang N, Serrano GE, Sue LI, Driver-Dunckley E, Mehta SH, Zamrini EE, Sabbagh MN, Shill HA, Belden CM, Shprecher DR, Caselli RJ, Reiman EM, Davis KJ, Long KE, Nicholson LR, Intorcia AJ, Glass MJ, Walker JE, Callan MM, Oliver JC, Arce R, Gerkin RC. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia. PLoS One. 2020; 15 (4):e0231720 Epub 2020 Apr 22
    View PubMed
39. Dong Q, Zhang J, Li Q, Wang J, Lepore N, Thompson PM, Caselli RJ, Ye J, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Integrating Convolutional Neural Networks and Multi-Task Dictionary Learning for Cognitive Decline Prediction with Longitudinal Images. J Alzheimers Dis. 2020; 75 (3):971-992
    View PubMed
40. Dong Q, Zhang W, Stonnington CM, Wu J, Gutman BA, Chen K, Su Y, Baxter LC, Thompson PM, Reiman EM, Caselli RJ, Wang Y. Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline. Neuroimage Clin. 2020; 27:102338 Epub 2020 July 05
    View PubMed
41. Stonnington CM, Velgos SN, Chen Y, Syed S, Huentelman M, Thiyyagura P, Lee W, Richholt R, Caselli RJ, Locke DEC, Lu B, Reiman EM, Su Y, Chen K. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline. J Alzheimers Dis. 2020; 78 (2):721-734
    View PubMed
42. Stonnington CM, Krell-Roesch J, Locke DEC, Hentz JG, Dueck AC, Geda YE, Tariot PN, Caselli RJ. Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec; 35:1533317519868370 Epub 2019 Aug 11
    View PubMed
43. Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Oijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. 2019 Jun; 137 (6):879-899 Epub 2019 Feb 09
    View PubMed
44. Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun. 2019 Apr 8; 10 (1):1619 Epub 2019 Apr 08
    View PubMed
45. Kuang L, Han X, Chen K, Caselli RJ, Reiman EM, Wang Y, Alzheimer's Disease Neuroimaging Initiative. A concise and persistent feature to study brain resting-state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative. Hum Brain Mapp. 2019 Mar; 40 (4):1062-1081 Epub 2018 Dec 19
    View PubMed
46. Fonseca-Portilla R, Krell-Roesch J, Shaibi GQ, Caselli RJ, Mandarino LJ, Zhang N, Hentz JG, Coletta DK, de Filippis EA, Dawit S, Geda YE. Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample. Metab Syndr Relat Disord. 2019 Mar; 17 (2):75-80 Epub 2018 Nov 10
    View PubMed
47. Dong Q, Zhang W, Wu J, Li B, Schron EH, McMahon T, Shi J, Gutman BA, Chen K, Baxter LC, Thompson PM, Reiman EM, Caselli RJ, Wang Y. Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects. Neuroimage Clin. 2019; 22:101744 Epub 2019 Mar 04
    View PubMed
48. Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. PLoS One. 2019; 14 (6):e0217566 Epub 2019 June 25
    View PubMed
49. Dong Q, Zhang J, Li Q, Thompson PM, Caselli RJ, Ye J, Wang Y. Multi-task dictionary learning based on convolutional neural networks for longitudinal clinical score predictions in Alzheimer's disease Communications in Computer and Information Science. 2019; 1072:21-35
    
50. Liu L, Caselli RJ. Unbalanced Sample Size Introduces Spurious Correlations to Genome-Wide Heterozygosity Analyses. Hum Hered. 2019; 84 (4-5):197-202 Epub 2020 June 15
    View PubMed
51. Dong Q, Zhang J, Li Q, Thompson PM, Caselli RJ, Ye J, Wang Y, Alzheimers Disease Neuroimaging Initiative. Multi-task Dictionary Learning based on Convolutional Neural Networks for Longitudinal Clinical Score Predictions in Alzheimer's Disease. Hum Brain Artif Intell (2019). 2019; 1072:21-35 Epub 2019 Nov 10
    View PubMed
52. Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, Liang WS, Caselli RJ, Shi J. Amyloid-beta Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease. Mol Neurobiol. 2018 Nov; 55 (11):8592-8601 Epub 2018 Mar 24
    View PubMed
53. Zhao N, Liu CC, Van Ingelgom AJ, Linares C, Kurti A, Knight JA, Heckman MG, Diehl NN, Shinohara M, Martens YA, Attrebi ON, Petrucelli L, Fryer JD, Wszolek ZK, Graff-Radford NR, Caselli RJ, Sanchez-Contreras MY, Rademakers R, Murray ME, Koga S, Dickson DW, Ross OA, Bu G. APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat Commun. 2018 Oct 22; 9 (1):4388
    View PubMed
54. Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A). Stem Cell Res. 2018 Oct; 32:145-149 Epub 2018 Sept 21
    View PubMed
55. Caselli RJ, Langlais BT, Dueck AC, Locke DEC, Woodruff BK. Subjective Cognitive Impairment and the Broad Autism Phenotype. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32 (4):284-290
    View PubMed
56. Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N, Petrucelli L, Wang LS, Schellenberg GD, Dickson DW, Rademakers R, Ross OA. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener. 2018 Jul 9; 13 (1):37 Epub 2018 July 09
    View PubMed
57. Limback-Stokin MM, Krell-Roesch J, Roesler K, Hansen A, Stonnington CM, Temkit M, Caselli RJ, Geda YE. Anticholinergic Medications and Cognitive Function in Late Midlife. Alzheimer Dis Assoc Disord. 2018 Jul-Sep; 32 (3):262-264
    View PubMed
58. Hanson KT, Zalewski NL, Hocker SE, Caselli RJ, Habermann EB, Thiels CA. At the Intersection of Patient Experience Data, Outcomes Research, and Practice: Analysis of HCAHPS Scores in Neurology Patients. Mayo Clin Proc Innov Qual Outcomes. 2018 Jun; 2 (2):137-147 Epub 2018 May 24
    View PubMed
59. Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, Lopez de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sanchez-Valle R, Antonell A, Llado A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Oijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol. 2018 Jun; 17 (6):548-558 Epub 2018 Apr 30
    View PubMed
60. Zhang J, Tu Y, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y. MULTI-TASK SPARSE SCREENING FOR PREDICTING FUTURE CLINICAL SCORES USING LONGITUDINAL CORTICAL THICKNESS MEASURES. Proc IEEE Int Symp Biomed Imaging. 2018 Apr; 2018:1406-1410 Epub 2018 May 24
    View PubMed
61. Wu J, Zhang J, Shi J, Chen K, Caselli RJ, Reiman EM, Wang Y. HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS. Proc IEEE Int Symp Biomed Imaging. 2018 Apr; 2018:1555-1559 Epub 2018 May 24
    View PubMed
62. Caselli RJ, Langlais BT, Dueck AC, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Locke DEC. Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment. J Am Geriatr Soc. 2018 Apr; 66(4):671-678. Epub 2018 Jan 17.
    View PubMed
63. Liu L, Caselli RJ. Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease. Alzheimers Dement (N Y). 2018; 4:602-608 Epub 2018 Oct 30
    View PubMed
64. Hansen A, Caselli RJ, Schlosser-Covell G, Golafshar MA, Dueck AC, Woodruff BK, Stonnington CM, Geda YE, Locke DEC. Neuropsychological comparison of incident MCI and prevalent MCI. Alzheimers Dement (Amst). 2018; 10:599-603 Epub 2018 Sept 27
    View PubMed
65. Tu Y, Wen C, Zhang W, Wu J, Zhang J, Chen K, Caselli RJ, Reiman EM, Wang Y. Isometry invariant shape descriptors for abnormality detection on brain surfaces affected by Alzheimer's disease Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2018; 2018-July:4627-31. Epub 1900 Jan 01.
    View PubMed
66. Gao F, Li J, Wu T, Chen K, Liu X, Baxter L, Caselli RJ. Bi-Threshold frequent subgraph mining for Alzheimer disease risk assessment Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2018; 10579:105790C. Epub 1900 Jan 01.
    
67. Stonnington CM, Chen Y, Savage CR, Lee W, Bauer III, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, Reiman EM, Chen K. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. J Alzheimers Dis. 2018; 63 (2):603-615
    View PubMed
68. Burns CM, Kaszniak AW, Chen K, Lee W, Bandy DJ, Caselli RJ, Reiman EM. Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions. J Alzheimers Dis. 2018; 62 (2):833-840
    View PubMed
69. Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Res. 2017 Dec; 25:266-269 Epub 2017 July 10
    View PubMed
70. Singh S, Srivastava A, Mi L, Caselli RJ, Chen K, Goradia D, Reiman EM, Wang Y. Deep Learning based Classification of FDG-PET Data for Alzheimers Disease Categories. Proc SPIE Int Soc Opt Eng. 2017 Oct; 10572 Epub 2017 Nov 17
    View PubMed
71. Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Res. 2017 Oct; 24:160-163 Epub 2017 June 08
    View PubMed
72. Delvaux E, Mastroeni D, Nolz J, Chow N, Sabbagh M, Caselli RJ, Reiman EM, Marshall FJ, Coleman PD. Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's. Neurobiol Aging. 2017 Oct; 58:225-237 Epub 2017 June 20
    View PubMed
73. Stonnington CM, Harel B, Locke DEC, Hentz JG, Zhang N, Maruff P, Caselli RJ. Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease. Alzheimer Dis Assoc Disord. 2017 Oct-Dec; 31 (4):271-277
    View PubMed
74. Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A, Matchett BJ, Mittag T, Temirov J, Hsiung GR, Krieger C, Murray ME, Kato M, Fryer JD, Petrucelli L, Zinman L, Weintraub S, Mesulam M, Keith J, Zivkovic SA, Hirsch-Reinshagen V, Roos RP, Zuchner S, Graff-Radford NR, Petersen RC, Caselli RJ, Wszolek ZK, Finger E, Lippa C, Lacomis D, Stewart H, Dickson DW, Kim HJ, Rogaeva E, Bigio E, Boylan KB, Taylor JP, Rademakers R. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017 Aug 16; 95 (4):808-816.e9
    View PubMed
75. Zhang J, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y. Multi-Source Multi-Target Dictionary Learning for Prediction of Cognitive Decline. Inf Process Med Imaging. 2017 Jun; 10265:184-197 Epub 2017 May 23
    View PubMed
76. Caselli RJ, Beach TG, Knopman DS, Graff-Radford NR. Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. Mayo Clin Proc. 2017 Jun; 92 (6):978-994
    View PubMed
77. Braden BB, Dassel KB, Bimonte-Nelson HA, O'Rourke HP, Connor DJ, Moorhous S, Sabbagh MN, Caselli RJ, Baxter LC. Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memory. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 May; 24 (3):227-246 Epub 2016 June 04
    View PubMed
78. Nielsen HM, Chen K, Lee W, Chen Y, Bauer RJ 3rd, Reiman E, Caselli R, Bu G. Peripheral apoE isoform levels in cognitively normal APOE epsilon3/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism. Alzheimers Res Ther. 2017 Jan 30; 9 (1):5
    View PubMed
79. Shi J, Zhang W, Tang M, Caselli RJ, Wang Y. Conformal invariants for multiply connected surfaces: Application to landmark curve-based brain morphometry analysis. Med Image Anal. 2017 Jan; 35:517-529 Epub 2016 Sept 06
    View PubMed
80. Han P, Serrano G, Beach TG, Caselli RJ, Yin J, Zhuang N, Shi J. A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor. J Neuropathol Exp Neurol. 2017 Jan 1; 76 (1):44-51
    View PubMed
81. Williams SM, Schulz P, Rosenberry TL, Caselli RJ, Sierks MR. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease. J Alzheimers Dis. 2017; 58 (1):23-35
    View PubMed
82. Caselli RJ, Woodruff BK. Clinical Impact of Amyloid Positron Emission Tomography-Is It Worth the Cost? JAMA Neurol 2016 Dec 1; 73 (12):1396-1398
    View PubMed
83. Zhang J, Shi J, Stonnington C, Li Q, Gutman BA, Chen K, Reiman EM, Caselli RJ, Thompson PM, Ye J, Wang Y. Hyperbolic Space Sparse Coding with Its Application on Prediction of Alzheimer's Disease in Mild Cognitive Impairment. Med Image Comput Comput Assist Interv. 2016 Oct; 9900:326-334 Epub 2016 Oct 02
    View PubMed
84. Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE. Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition. J Neuropathol Exp Neurol. 2016 Aug; 75 (8):748-754 Epub 2016 June 12
    View PubMed
85. Caselli RJ, Dueck AC, Locke DE, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Geda YE. Impact of Personality on Cognitive Aging: A Prospective Cohort Study. J Int Neuropsychol Soc. 2016 Aug; 22 (7):765-76 Epub 2016 June 27
    View PubMed
86. Weissenbacher D, Johnson AT, Wojtulewicz L, Dueck AL, Locke D, Caselli R, Gonzalez G. Towards automatic detection of abnormal cognitive decline and dementia through linguistic analysis of writing samples. Proceedings of NAACL-HLT. 2016 Jun 12-17; 1198-1207.
    
87. Zhang W, Shi J, Stonnington C, Bauer RJ 3rd, Gutman BA, Chen K, Thompson PM, Reiman EM, Caselli RJ, Wang Y. MORPHOMETRIC ANALYSIS OF HIPPOCAMPUS AND LATERAL VENTRICLE REVEALS REGIONAL DIFFERENCE BETWEEN COGNITIVELY STABLE AND DECLINING PERSONS. Proc IEEE Int Symp Biomed Imaging. 2016 Apr; 2016:14-18
    View PubMed
88. Li B, Shi J, Gutman BA, Baxter LC, Thompson PM, Caselli RJ, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study. PLoS One. 2016; 11 (4):e0152901 Epub 2016 Apr 11
    View PubMed
89. Zhang J, Shi J, Stonnington C, Li Q, Gutman BA, Chen K, Reiman EM, Caselli R, Thompson PM, Ye J, Wang Y. Hyperbolic space sparse coding with its application on prediction of Alzheimer’s disease in mild cognitive impairment Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2016; 9900 LNCS:326-34. Epub 1900 Jan 01.
    
90. Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM. Characterizing Apolipoprotein E epsilon4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal beta-Amyloid Peptide Plaques. JAMA Neurol. 2015 Oct; 72 (10):1124-31
    View PubMed
91. Krell-Roesch J, Woodruff BK, Acosta JI, Locke DE, Hentz JG, Stonnington CM, Stokin GB, Nagle C, Michel BF, Sambuchi N, Caselli RJ, Geda YE. APOE epsilon4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons. J Neuropsychiatry Clin Neurosci. 2015 Fall; 27 (4):322-5 Epub 2015 Mar 24
    View PubMed
92. Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment. BMC Neurol. 2015 Aug 20; 15:146
    View PubMed
93. Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology. 2015 Aug; 35 (4):354-89 Epub 2015 Jan 26
    View PubMed
94. Caselli RJ, Marchant GE, Hunt KS, Henslin BR, Kosiorek HE, Langbaum J, Robert JS, Dueck AC. Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants. Alzheimer Dis Assoc Disord. 2015 Jul-Sep; 29 (3):252-4
    View PubMed
95. Wang G, Zhang X, Su Q, Shi J, Caselli RJ, Wang Y, Alzheimer's Disease Neuroimaging Initiative. A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel. Med Image Anal. 2015 May; 22 (1):1-20 Epub 2015 Feb 03
    View PubMed
96. Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, Jagust WJ, Weiner MW, Reiman EM, Alzheimer's Disease Neuroimaging Initiative. Improved power for characterizing longitudinal amyloid-beta PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med. 2015 Apr; 56 (4):560-6 Epub 2015 Mar 05
    View PubMed
97. Han P, Caselli RJ, Baxter L, Serrano G, Yin J, Beach TG, Reiman EM, Shi J. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. JAMA Neurol. 2015 Mar; 72 (3):333-9
    View PubMed
98. Caselli RJ, Dueck AC, Locke DE, Baxter LC, Woodruff BK, Geda YE. Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct? J Int Neuropsychol Soc. 2015 Feb; 21 (2):95-104 Epub 2015 Feb 09
    View PubMed
99. Schlosser Covell GE, Hoffman-Snyder CR, Wellik KE, Woodruff BK, Geda YE, Caselli RJ, Demaerschalk BM, Wingerchuk DM. Physical activity level and future risk of mild cognitive impairment or dementia: a critically appraised topic. Neurologist. 2015 Feb; 19: (3)89-91.
    View PubMed
100. Kennedy DM, Nordrum JT, Edwards FD, Caselli RJ, Berry LL. Improving service quality in primary care. Am J Med Qual. 2015 Jan-Feb; 30: (1)45-51.
     View PubMed
101. Shi J, Stonnington CM, Thompson PM, Chen K, Gutman B, Reschke C, Baxter LC, Reiman EM, Caselli RJ, Wang Y, Alzheimer's Disease Neuroimaging Initiative. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. Neuroimage. 2015 Jan 1; 104:1-20 Epub 2014 Oct 05
     View PubMed
102. Snyder PJ, Kahle-Wrobleski K, Brannan S, Miller DS, Schindler RJ, DeSanti S, Ryan JM, Morrison G, Grundman M, Chandler J, Caselli RJ, Isaac M, Bain L, Carrillo MC. Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools? Alzheimers Dement. 2014 Nov; 10 (6):853-60 Epub 2014 Nov 15
     View PubMed
103. van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Neumann M, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging. 2014 Oct; 35 (10):2421.e13-7 Epub 2014 May 02
     View PubMed
104. Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, Henslin BR, Dueck AC, Robert JS. Public perceptions of presymptomatic testing for Alzheimer disease. Mayo Clin Proc. 2014 Oct; 89 (10):1389-96 Epub 2014 Aug 26
     View PubMed
105. Caselli RJ. Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy? Pediatr Blood Cancer. 2014 Oct; 61(10):1739-42. Epub 2013 Sep 17.
     View PubMed
106. van Blitterswijk M, Mullen B, Wojtas A, Heckman MG, Diehl NN, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Neumann M, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener. 2014 Sep 20; 9:38 Epub 2014 Sept 20
     View PubMed
107. McCormick JB, Sharp RR, Farrugia G, Lindor NM, Babovic-Vuksanovic D, Borad MJ, Bryce AH, Caselli RJ, Ferber MJ, Johnson KJ, Lazaridis KN, McWilliams RR, Murray JA, Parker AS, Schahl KA, Wieben ED. Genomic medicine and incidental findings: balancing actionability and patient autonomy. Mayo Clin Proc 2014 Jun; 89 (6):718-21
     View PubMed
108. Han P, Liang W, Baxter LC, Yin J, Tang Z, Beach TG, Caselli RJ, Reiman EM, Shi J. Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease. Neurology. 2014 May 13; 82 (19):1724-8 Epub 2014 Apr 09
     View PubMed
109. van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol. 2014 Mar; 127 (3):397-406 Epub 2014 Jan 03
     View PubMed
110. Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. 2014 Feb; 127 (2):271-82
     View PubMed
111. Caselli RJ, Chen K, Locke DE, Lee W, Roontiva A, Bandy D, Fleisher AS, Reiman EM. Subjective cognitive decline: self and informant comparisons. Alzheimers Dement. 2014 Jan; 10 (1):93-8 Epub 2013 Apr 03
     View PubMed
112. Stonnington CM, Chen K, Lee W, Locke DE, Dueck AC, Liu X, Roontiva A, Fleisher AS, Caselli RJ, Reiman EM. Fibrillar amyloid correlates of preclinical cognitive decline. Alzheimers Dement. 2014 Jan; 10 (1):e1-8 Epub 2013 Apr 11
     View PubMed
113. Caselli RJ, Locke DE, Dueck AC, Knopman DS, Woodruff BK, Hoffman-Snyder C, Rademakers R, Fleisher AS, Reiman EM. The neuropsychology of normal aging and preclinical Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10 (1):84-92 Epub 2013 Mar 26
     View PubMed
114. Locke DE, Dueck AC, Stonnington CM, Knopman DS, Geda YE, Caselli RJ. Depressive symptoms in healthy apolipoprotein E epsilon4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry. 2013 Dec; 74 (12):1256-61
     View PubMed
115. van Blitterswijk M, Baker MC, Bieniek KF, Knopman DS, Josephs KA, Boeve B, Caselli R, Wszolek ZK, Petersen R, Graff-Radford NR, Boylan KB, Dickson DW, Rademakers R. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep; 14 (5-6):463-9 Epub 2013 May 02
     View PubMed
116. Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013 Aug; 14 (8):754-62 Epub 2013 Mar 07
     View PubMed
117. Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM. Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol. 2013 Jul; 9(7):371-81. Epub 2013 Jun 11.
     View PubMed
118. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Younkin SG, Petersen RC, Ertekin-Taner N, Uitti RJ, Meschia JF, Boylan KB, Boeve BF, Graff-Radford NR, Wszolek ZK, Dickson DW, Rademakers R, Ross OA. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener. 2013 Jun 21; 8:19 Epub 2013 June 21
     View PubMed
119. Burns CM, Chen K, Kaszniak AW, Lee W, Alexander GE, Bandy D, Fleisher AS, Caselli RJ, Reiman EM. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology. 2013 Apr 23; 80(17):1557-64. Epub 2013 Mar 27.
     View PubMed
120. Wolf AB, Caselli RJ, Reiman EM, Valla J. APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging. 2013 Apr; 34(4):1007-17. Epub 2012 Nov 16.
     View PubMed
121. Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 2013 Mar 1; 70(3):320-5.
     View PubMed
122. Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, Muñoz C, Ramirez-Restrepo M, Gaiteri C, Myers AJ, Caselli RJ, Kosik KS, Reiman EM, Huentelman MJ. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol Aging. 2013; 34(8):2077.e1-18.
     View PubMed
123. Lu PH, Mendez MF, Lee GJ, Leow AD, Lee HW, Shapira J, Jimenez E, Boeve BB, Caselli RJ, Graff-Radford NR, Jack CR, Kramer JH, Miller BL, Bartzokis G, Thompson PM, Knopman DS. Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2013; 35 (1-2):34-50 Epub 2013 Jan 09
     View PubMed
124. Caselli RJ, Reiman EM. Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention. J Alzheimers Dis. 2013; 33 Suppl 1 (0 1):S405-16
     View PubMed
125. Schraml F, Chen K, Ayutyanont N, Auttawut R, Langbaum JB, Lee W, Liu X, Bandy D, Reeder SQ, Alexander GE, Caselli RJ, Fleisher AS, Reiman EM, the Alzheimer's Disease Neuroimaging Initiative. Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. PLoS One. 2013; 8(6):e67163. Epub 2013 Jun 26
     View PubMed
126. Wolf AB, Valla J, Bu G, Kim J, LaDu MJ, Reiman EM, Caselli RJ. Apolipoprotein E as a beta-amyloid-independent factor in Alzheimer's disease. Alzheimers Res Ther. 2013; 5 (5):38 Epub 2013 Sept 03
     View PubMed
127. Alexander GE, Bergfield KL, Chen K, Reiman EM, Hanson KD, Lin L, Bandy D, Caselli RJ, Moeller JR. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults. Neurobiol Aging. 2012 Dec; 33(12):2723-32. Epub 2012 Mar 08.
     View PubMed
128. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL 3rd, Mackenzie IR, Petersen RC, Strong MJ, Miller BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging. 2012 Dec; 33 (12):2950.e5-7 Epub 2012 July 26
     View PubMed
129. Caselli RJ, Dueck AC, Huentelman MJ, Lutz MW, Saunders AM, Reiman EM, Roses AD. Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement. 2012 Nov; 8 (6):490-5
     View PubMed
130. Schlosser Covell GE, Dhawan PS, Lee Iannotti JK, Hoffman-Snyder CR, Wellik KE, Caselli RJ, Woodruff BK, Wingerchuk DM, Demaerschalk BM. Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic. Neurologist. 2012 Nov; 18: (6)426-9.
     View PubMed
131. Kennedy DM, Caselli RJ, Berry LL. Healthy returns: An inside look at Mayo Clinic Arizona's 7-ste approach to improve service and delight customers. Quality Progress. 2012 Oct:32-9.
     
132. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton MK, Preza E, Lovestone S, Powell J, Graff-Radford N, Petersen RC, Boeve BF, Lippa CF, Bigio EH, Mackenzie I, Finger E, Kertesz A, Caselli RJ, Gearing M, Juncos JL, Ghetti B, Spina S, Bordelon YM, Tourtellotte WW, Frosch MP, Vonsattel JP, Zarow C, Beach TG, Albin RL, Lieberman AP, Lee VM, Trojanowski JQ, Van Deerlin VM, Bird TD, Galasko DR, Masliah E, White CL, Troncoso JC, Hannequin D, Boxer AL, Geschwind MD, Kumar S, Mandelkow EM, Wszolek ZK, Uitti RJ, Dickson DW, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Ross OA, Rademakers R, Schellenberg GD, Miller BL, Mandelkow E, Geschwind DH, Alzheimer's Disease Genetics Consortium. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 1; 21 (15):3500-12 Epub 2012 May 03
     View PubMed
133. Caselli RJ. Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications. Alzheimers Res Ther. 2012 Jun 14; 4 (3):20 Epub 2012 June 14
     View PubMed
134. Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Caselli RJ, Reiman EM. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E epsilon4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares. Neuroimage. 2012 May 1; 60(4):2316-22. Epub 2012 Feb 12.
     View PubMed
135. Langbaum JB, Chen K, Launer LJ, Fleisher AS, Lee W, Liu X, Protas HD, Reeder SA, Bandy D, Yu M, Caselli RJ, Reiman EM. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging. 2012 Apr; 33(4):827.e11-9. Epub 2011 Aug 06.
     View PubMed
136. Mateen FJ, Josephs KA, Parisi JE, Drubach DA, Caselli RJ, Kantarci K, Jack C Jr, Boeve BF. Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series. Neurocase. 2012 Feb; 18: (1)1-12.
     View PubMed
137. Caselli RJ, Reiman EM. Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention. Advances in Alzheimer's Disease. 2012; 3:405-16.
     
138. Kennedy DM, Caselli RJ, Berry LL. Mayo Clinic Arizona's 7-step approach to improve service and delight customers. Quality Progress. 2012; 45(10):32-9.
     
139. Knopman DS, Caselli RJ. Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review. Neurodegener Dis Manag. 2012; 2 (2):183-195
     View PubMed
140. Kennedy DM, Caselli RJ, Berry LL. A roadmap for improving healthcare service quality. J Healthc Manag. 2011 Nov-Dec; 56(6):385-400; discussion 400-2.
     View PubMed
141. Locke DE, Stonnington CM, Thomas ML, Caselli RJ. Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging. J Clin Exp Neuropsychol. 2011 Oct; 33 (8):937-43 Epub 2011 June 27
     View PubMed
142. Stonnington CM, Locke DE, Dueck AC, Caselli RJ. Anxiety affects cognition differently in healthy apolipoprotein E epsilon4 homozygotes and non-carriers. J Neuropsychiatry Clin Neurosci. 2011 Summer; 23(3):294-9.
     View PubMed
143. Caselli RJ, Dueck AC, Locke DE, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM. Longitudinal modeling of frontal cognition in APOE epsilon4 homozygotes, heterozygotes, and noncarriers. Neurology. 2011 Apr 19; 76 (16):1383-8
     View PubMed
144. Flanagan EP, Caselli RJ. Autoimmune encephalopathy. Semin Neurol. 2011 Apr; 31 (2):144-57 Epub 2011 May 17
     View PubMed
145. Bunyan RF, Popescu BF, Carter JL, Caselli RJ, Parisi JE, Lucchinetti CF. Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol. 2011 Apr; 68 (4):525-8
     View PubMed
146. Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Hoffman-Snyder C, Rademakers R, Findley S, Reiman EM. Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology. 2011 Mar 22; 76 (12):1078-84 Epub 2011 Feb 16
     View PubMed
147. Riordan KC, Hoffman Snyder CR, Wellik KE, Caselli RJ, Wingerchuk DM, Demaerschalk BM. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic. Neurologist. 2011 Mar; 17 (2):121-3
     View PubMed
148. Liang WS, Chen K, Lee W, Sidhar K, Corneveaux JJ, Allen AN, Myers A, Villa S, Meechoovet B, Pruzin J, Bandy D, Fleisher AS, Langbaum JB, Huentelman MJ, Jensen K, Dunckley T, Caselli RJ, Kaib S, Reiman EM. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEepsilon4 carriers. Neuroimage. 2011 Feb 1; 54(3):1896-902. Epub 2010 Oct 01.
     View PubMed
149. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, Knopman DS, Uitti R, White CL 3rd, Caselli R, Lippa C, Bigio EH, Wszolek ZK, Binetti G, Mackenzie IR, Miller BL, Boeve BF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Geschwind DH, Rademakers R. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011 Feb 1; 76 (5):467-74 Epub 2010 Dec 22
     View PubMed
150. Reiman EM, Langbaum JBS, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, Quiroz YT, Kosik KS, Lopera F, Tariot PN. Alzheimers prevention initiative: A plan to accelerate the evaluation of presymptomatic treatments. J Alzheimer's Dis. 2011; 26(Suppl 3):321-9.
     View PubMed
151. Liang WS, Chen K, Lee W, Sidhar K, Corneveaux JJ, Allen AN, Myers A, Villa S, Meechoovet B, Pruzin J, Bandy D, Fleisher AS, Langbaum JBS, Huentelman MJ, Jensen K, Dunckley T, Caselli RJ, Kaib S, Reiman EM. Corrigendum to "Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOE epsilon 4 carriers" [NeuroImage 54/3 (2011) 1896-1902]. Neuroimage. 2011; 58(3):974.
     
152. Pakhomov SV, Smith GE, Chacon D, Feliciano Y, Graff-Radford N, Caselli R, Knopman DS. Computerized analysis of speech and language to identify psycholinguistic correlates of frontotemporal lobar degeneration. Cogn Behav Neurol. 2010 Sep; 23 (3):165-77
     View PubMed
153. Corneveaux JJ, Liang WS, Reiman EM, Webster JA, Myers AJ, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Craig DW, Coon KD, Dunckley T, Bandy D, Lee W, Chen K, Beach TG, Mastroeni D, Grover A, Ravid R, Sando SB, Aasly JO, Heun R, Jessen F, Kolsch H, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Papassotiropoulos A, Stephan DA, Huentelman MJ. Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging. 2010 Jun; 31(6):901-9. Epub 2008 Sep 13.
     View PubMed
154. Caselli RJ, Walker D, Sue L, Sabbagh M, Beach T. Amyloid load in nondemented brains correlates with APOE e4. Neurosci Lett. 2010 Apr 12; 473 (3):168-71 Epub 2010 Feb 12
     View PubMed
155. Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Arch Neurol. 2010 Apr; 67(4):462-8.
     View PubMed
156. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging. 2010 Apr; 31(4):549-66. Epub 2008 Jun 24.
     View PubMed
157. Bei Hu Hu, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL. Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2010 Mar; 25 (2):128-33 Epub 2010 Feb 01
     View PubMed
158. Pakhomov SV, Smith GE, Marino S, Birnbaum A, Graff-Radford N, Caselli R, Boeve B, Knopman DS. A computerized technique to assess language use patterns in patients with frontotemporal dementia. J Neurolinguistics. 2010 Mar 1; 23 (2):127-144
     View PubMed
159. Reiman EM, Chen K, Langbaum JB, Lee W, Reschke C, Bandy D, Alexander GE, Caselli RJ. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage. 2010 Jan 1; 49(1):169-76. Epub 2009 Jul 23.
     View PubMed
160. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis. 2010; 22(1):307-13.
     View PubMed
161. Pollen DA, Baker S, Hinerfeld D, Swearer J, Evans BA, Evans JE, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M. Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4. Alzheimers Res Ther. 2010; 2(5):31. Epub 2010 Oct 29.
     View PubMed
162. Webster J, Reiman EM, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Rogers J, Heun R, Jessen F, Kolsch H, Heward CB, Ravid R, Hutton ML, Melquist S, Petersen RC, Caselli RJ, Papassotiropoulos A, Stephan DA, Hardy J, Myers A. Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. Int J Mol Epidemiol Genet. 2010; 1(1):19-30. Epub 2009 Jul 26.
     View PubMed
163. Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. J Clin Psychiatry. 2009 Oct; 70(10):1379-84. Epub 2009 Jun 30.
     View PubMed
164. Caselli RJ. Creativity: an organizational schema. Cogn Behav Neurol. 2009 Sep; 22(3):143-54.
     View PubMed
165. Chen K, Reiman EM, Huan Z, Caselli RJ, Bandy D, Ayutyanont N, Alexander GE. Linking functional and structural brain images with multivariate network analyses: a novel application of the partial least square method. Neuroimage. 2009 Aug 15; 47(2):602-10. Epub 2009 Apr 23.
     View PubMed
166. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Frisardi V, Scapicchio P, Chiloiro R, Scafato E, Gandin C, Vendemiale G, Capurso A, Solfrizzi V. Temporal relationship between depressive symptoms and cognitive impairment: The Italian Longitudinal Study on Aging. J Alzheimer's Dis. 2009 Aug; 17(4):899-911.
     View PubMed
167. Caselli RJ. Age-related memory decline and apolipoprotein E e4. Discov Med. 2009 Aug; 8(41):47-50.
     View PubMed
168. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med. 2009 Jul 16; 361 (3):255-63
     View PubMed
169. Almaraz AC, Driver-Dunckley ED, Woodruff BK, Wellik KE, Caselli RJ, Demaerschalk BM, Adler CH, Caviness JN, Wingerchuk DM. Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist. 2009 Jul; 15(4):234-7.
     View PubMed
170. Knopman DS, Jack CR Jr, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo ND. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology. 2009 May 26; 72 (21):1843-9
     View PubMed
171. Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Apr 21; 106(16):6820-5. Epub 2009 Apr 03.
     View PubMed
172. Evans BA, Evans JE, Baker SP, Kane K, Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M, Pollen DA. Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 27(6):519-24. Epub 2009 May 29.
     View PubMed
173. Locke DE, Dassel KB, Hall G, Baxter LC, Woodruff BK, Hoffman Snyder C, Miller BL, Caselli RJ. Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire. Dement Geriatr Cogn Disord. 2009; 27 (3):260-72 Epub 2009 Feb 25
     View PubMed
174. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Dickson DW. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet. 2008 Dec 1; 17 (23):3631-42 Epub 2008 Aug 21
     View PubMed
175. Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo N. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008 Nov; 131 (Pt 11):2957-68 Epub 2008 Oct 01
     View PubMed
176. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve B, Graff-Radford NR, Wszolek ZK, Caselli RJ, Dickson DW, Mackenzie IR, Petrucelli L, Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008 Sep 19; 4 (9):e1000193 Epub 2008 Sept 19
     View PubMed
177. Caselli RJ, Chen K, Lee W, Alexander GE, Reiman EM. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Arch Neurol. 2008 Sep; 65 (9):1231-6
     View PubMed
178. Winton MJ, Van Deerlin VM, Kwong LK, Yuan W, Wood EM, Yu CE, Schellenberg GD, Rademakers R, Caselli R, Karydas A, Trojanowski JQ, Miller BL, Lee VM. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett. 2008 Jun 25; 582(15):2252-6. Epub 2008 May 27.
     View PubMed
179. Lyons MK, Caselli RJ, Parisi JE. Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. J Neurosurg. 2008 May; 108(5):1024-7.
     View PubMed
180. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics. 2008 Apr 22; 33(2):240-56. Epub 2008 Feb 12.
     View PubMed
181. Reiman EM, Chen K, Caselli RJ, Alexander GE, Bandy D, Adamson JL, Lee W, Cannon A, Stephan EA, Stephan DA, Papassotiropoulos A. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. Neuroimage. 2008 Apr 15; 40(3):1214-21. Epub 2008 Jan 17.
     View PubMed
182. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008 Apr; 63(4):535-8.
     View PubMed
183. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4441-6. Epub 2008 Mar 10.
     View PubMed
184. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, Kurz A, Minoshima S, de Leon MJ. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med. 2008 Mar; 49(3):390-8. Epub 2008 Feb 20.
     View PubMed
185. Schrader SL, Wellik KE, Demaerschalk BM, Caselli RJ, Woodruff BK, Wingerchuk DM. Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist. 2008 Mar; 14(2):134-7.
     View PubMed
186. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Todarello O, Pellicani V, Santamato A, Scapicchio P, Maggi S, Scafato E, Gandin C, Capurso A, Solfrizzi V, Italian Longitudinal Study on Aging Working Group. Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2008; 25(4):336-46. Epub 2008 Mar 05.
     View PubMed
187. Caselli RJ, Yaari R. Medical management of frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2007 Dec-2008 Jan; 22(6):489-98.
     View PubMed
188. Knopman DS, Boeve BS, Caselli RJ, Graff-Radford NR, Kramer JH, Mendez MF, Miller BL. Longitudinal tracking of FTLD: toward developing clinical trial methodology. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21 (4):S58-63
     View PubMed
189. Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol. 2007 Sep; 64 (9):1306-11
     View PubMed
190. Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chio A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, Hutton M, Gass J, Cannon A, Rademakers R, Singleton AB, Hardiman O, Rothstein J, Hardy J, Traynor BJ. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry. 2007 Jul; 78 (7):754-6 Epub 2007 Mar 19
     View PubMed
191. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007 Jun 7; 54(5):713-20.
     View PubMed
192. Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry. 2007 Jun; 164(6):916-21.
     View PubMed
193. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr; 80 (4):769-78 Epub 2007 Mar 08
     View PubMed
194. Hickey MG, Demaerschalk BM, Caselli RJ, Parish JM, Wingerchuk DM. "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist. 2007 Mar; 13(2):98-101.
     View PubMed
195. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette C, Schmechel D, Alexander GE, Reiman EM, Rogers J, Stephan DA. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics. 2007 Feb 12; 28(3):311-22. Epub 2006 Oct 31.
     View PubMed
196. Etnier JL, Caselli RJ, Reiman EM, Alexander GE, Sibley BA, Tessier D, McLemore EC. Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med Sci Sports Exerc. 2007 Jan; 39(1):199-207.
     View PubMed
197. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Scapicchio PL, Scafato E, Gandin C, Capurso A, Panza F, Italian Longitudinal Study on Aging Working Group. Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2007; 24(1):55-64. Epub 2007 Jun 11.
     View PubMed
198. Valla J, Schneider L, Niedzielko T, Coon KD, Caselli R, Sabbagh MN, Ahern GL, Baxter L, Alexander G, Walker DG, Reiman EM. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion. 2006 Dec; 6(6):323-30. Epub 2006 Oct 27.
     View PubMed
199. Caselli RJ, Beach TG, Yaari R, Reiman EM. Alzheimer's disease a century later. J Clin Psychiatry. 2006 Nov; 67 (11):1784-800
     View PubMed
200. Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, Pearson JV, Huynh KD, Brunner F, Corneveaux J, Osborne D, Wollmer MA, Aerni A, Coluccia D, Hanggi J, Mondadori CR, Buchmann A, Reiman EM, Caselli RJ, Henke K, de Quervain DJ. Common Kibra alleles are associated with human memory performance. Science. 2006 Oct 20; 314(5798):475-8.
     View PubMed
201. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White CL 3rd, Woodruff B, Caselli R, Hsiung GY, Feldman H, Knopman D, Hutton M, Rademakers R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006 Oct 15; 15 (20):2988-3001 Epub 2006 Sept 01
     View PubMed
202. Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, LaFleur BJ, Coon KD, Brown KM, Caselli R, Kukull W, Higdon R, McKeel D, Morris JC, Hulette C, Schmechel D, Reiman EM, Rogers J, Stephan DA. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging. 2006 Oct; 27(10):1359-71. Epub 2005 Oct 19.
     View PubMed
203. Coon KD, Valla J, Szelinger S, Schneider LE, Niedzielko TL, Brown KM, Pearson JV, Halperin R, Dunckley T, Papassotiropoulos A, Caselli RJ, Reiman EM, Stephan DA. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion. 2006 Aug; 6(4):194-210. Epub 2006 Jul 21.
     View PubMed
204. Alexander GE, Chen K, Merkley TL, Reiman EM, Caselli RJ, Aschenbrenner M, Santerre-Lemmon L, Lewis DJ, Pietrini P, Teipel SJ, Hampel H, Rapoport SI, Moeller JR. Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport. 2006 Jul 17; 17(10):951-6.
     View PubMed
205. Panza F, D'Introno A, Colacicco AM, Capurso C, Parigi AD, Capurso SA, Caselli RJ, Pilotto A, Scafato E, Capurso A, Solfrizzi V. Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging. 2006 Jul; 27(7):933-40. Epub 2005 Jul 14.
     View PubMed
206. Caselli RJ, Chen K, Bandy D, Smilovici O, Boeve BF, Osborne D, Alexander GE, Parish JM, Krahn LE, Reiman EM. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep. 2006 Jul; 29 (7):927-33
     View PubMed
207. Hoffman Snyder C, Mishark KJ, Caviness JN, Drazkowski JF, Caselli RJ. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol. 2006 May; 63(5):766-8.
     View PubMed
208. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63 (2):197-202
     View PubMed
209. Schwedt TJ, Dodick DW, Caselli RJ. Giant cell arteritis. Current Pain and Headache Reports. 2006; 10:415-20.
     
210. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005 Aug; 20(8):982-8.
     View PubMed
211. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Pilotto A, Argentieri G, Scapicchio PL, Scafato E, Capurso A, Solfrizzi V. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry. 2005 Aug; 13(8):633-44.
     View PubMed
212. Reiman EM, Chen KW, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Correlations between apolipoprotein E epsilon 4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A. 2005 Jun 7; 102(23):8299-302.
     View PubMed
213. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004 Nov 23; 63(10):1882-91.
     View PubMed
214. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, Caselli RJ, Knopman DS, Petersen RC. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004 Oct 12; 63 (7):1168-74
     View PubMed
215. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology. 2004 Jun 8; 62 (11):1990-5
     View PubMed
216. Reiman EM, Chen KW, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A. 2004 Jan 6; 101(1):284-9.
     View PubMed
217. Caselli RJ, Reiman EM, Hentz JG, Osborne D, Alexander GE. A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. J Neuropsychiatry Clin Neurosci 2004 Sum; 16(3):320-9.
     View PubMed
218. Johnson SC, Baxter LC, Susskind-Wilder L, Connor DJ, Sabbagh MN, Caselli RJ. Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia. 2004; 42(7):980-9.
     View PubMed
219. Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborne D. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging. 2003 Nov; 24(7):947-52.
     View PubMed
220. Caselli RJ. Current issues in the diagnosis and management of dementia. Semin Neurol. 2003 Sep; 23(3):231-40.
     View PubMed
221. Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D, Baker M, Sahara N, Yen SH, Hutton M, Caselli R, Adler C, Connor D, Sabbagh M. Hippocampal sclerosis dementia with tauopathy. Brain Pathol. 2003 Jul; 13(3):263-78.
     View PubMed
222. Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W. Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol. 2003; 54(Suppl 5):S20-3.
     View PubMed
223. Caviness JN, Adler CH, Beach TG, Wetjen KL, Caselli RJ. Small-amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations. Mov Disord. 2002 Jul; 17(4):657-62.
     View PubMed
224. Caselli RJ, Reiman EM, Hentz JG, Osborne D, Alexander GE, Boeve BF. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep. 2002 Jun 15; 25(4):447-53.
     View PubMed
225. Caselli RJ, Hentz JG, Osborne D, Graff-Radford NR, Barbieri CJ, Alexander GE, Hall GR, Reiman EM, Hardy J, Saunders AM. Apolipoprotein E and intellectual achievement. J Am Geriatr Soc. 2002 Jan; 50 (1):49-54
     View PubMed
226. Caviness JN, Smith BE, Clarke Stevens J, Stevens JC, Adler CH, Caselli RJ, Hentz JG, Manfred MS, Muenter D. Motor unit number estimates in idiopathic Parkinson's disease. Parkinsonism Relat Disord. 2002 Jan; 8 (3):161-4
     View PubMed
227. Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, Dickson DW, Hutton M, Hardy J, Caselli RJ, Petersen RC. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement Geriatr Cogn Disord. 2002; 13 (2):80-90
     View PubMed
228. Caselli RJ, Beach TG, Sue LI, Connor DJ, Sabbagh MN. Progressive aphasia with Lewy bodies. Dement Geriatr Cogn Disord. 2002; 14 (2):55-8
     View PubMed
229. Caviness JN, Adler CH, Beach TG, Wetjen KL, Caselli RJ. Myoclonus in Lewy body disorders. Adv Neurol. 2002; 89:23-30.
     View PubMed
230. Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE. Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J Neurol Sci. 2001 Aug 15; 189 (1-2):93-8
     View PubMed
231. Reiman EM, Caselli RJ, Alexander GE, Chen KW. Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease. Clinical Neuroscience Research. 2001 May; 1(3):194-206.
     
232. Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3334-9.
     View PubMed
233. Caviness JN, Smith BE, Stevens JC, Adler CH, Caselli RJ, Reiners CA, Hentz JG, Muenter MD. Motor unit changes in sporadic idiopathic Parkinson's disease. Mov Disord. 2000 Mar; 15 (2):238-43
     View PubMed
234. Caselli RJ. Focal and asymmetric cortical degenerative syndromes. Adv Neurol. 2000; 82:35-51.
     View PubMed
235. Caselli RJ. Visual syndromes as the presenting feature of degenerative brain disease. Semin Neurol. 2000; 20 (1):139-44
     View PubMed
236. Newman MC, Holland AL, Caselli RJ, Gongoll R, White K, Reiman EM. Talkativeness in cognitively normal women at genetic risk of Alzheimer's disease. Aging, Neuropsychology and Cognition. 2000; 7(4):217-26.
     
237. Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999 Oct 22; 53 (7):1579-81
     View PubMed
238. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999 Sep 11; 53 (4):795-800
     View PubMed
239. Caselli RJ, Graff-Radford NR, Reiman EM, Weaver A, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology. 1999 Jul 13; 53 (1):201-7
     View PubMed
240. Reiman EM, Caselli RJ. Alzheimer's disease. Maturitas. 1999 Mar 15; 31(3):185-200.
     View PubMed
241. Caselli RJ, Stelmach GE, Caviness JN, Timmann D, Royer T, Boeve BF, Parisi JE. A kinematic study of progressive apraxia with and without dementia. Mov Disord. 1999 Mar; 14 (2):276-87
     View PubMed
242. Caselli RJ, Couce ME, Osborne D, Deen HG, Parisi JP. From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease. Alzheimer Dis Assoc Disord. 1998 Sep; 12(3):251-3.
     View PubMed
243. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol. 1998 Aug; 44(2):288-91.
     View PubMed
244. Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM Jr, Snow BJ, Calne DB. Hereditary form of parkinsonism--dementia. Ann Neurol. 1998 Jun; 43: (6)768-81.
     View PubMed
245. Caviness JN, Adler CH, Newman S, Caselli RJ, Muenter MD. Cortical myoclonus in levodopa-responsive parkinsonism. Mov Disord. 1998 May; 13(3):540-4.
     View PubMed
246. Caselli RJ, Hunder GG. Giant cell (temporal) arteritis. Neurol Clin. 1997 Nov; 15 (4):893-902
     View PubMed
247. Caselli RJ. Asymmetric cortical degeneration syndromes. Curr Opin Neurol. 1996 Aug; 9 (4):276-80
     View PubMed
248. Reed CL, Caselli RJ, Farah MJ. Tactile agnosia. Underlying impairment and implications for normal tactile object recognition. Brain. 1996 Jun; 119(Pt 3):875-88.
     View PubMed
249. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996 Mar 21; 334(12):752-8.
     View PubMed
250. Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology. 1995 Nov; 45 (11):2005-9
     View PubMed
251. Caselli RJ, Reiman EM, Timmann D, Stelmach GE, Lawson MA, Osborne D, Moore SB, Cevette MJ. Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol. 1995 Oct; 52 (10):1004-10
     View PubMed
252. Caselli RJ. Asymmetric cortical degeneration: syndromes and diseases. Neurologist. 1995; 1:1-20.
     
253. Caselli RJ, Hunder GG. Neurologic complications of giant cell (temporal) arteritis. Semin Neurol. 1994 Dec; 14(4):349-53.
     View PubMed
254. Pestronk A, Choksi R, Bieser K, Goldstein JM, Adler CH, Caselli RJ, George EB. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein. Muscle & Nerve. 1994 Nov; 17(11):1293-300.
     View PubMed
255. Reed CL, Caselli RJ. The nature of tactile agnosia: a case study. Neuropsychologia. 1994 May; 32(5):527-39.
     View PubMed
256. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am. 1993 Nov; 19(4):941-53.
     View PubMed
257. Graff-Radford NR, Bolling JP, Earnest F 4th, Shuster EA, Caselli RJ, Brazis PW. Simultanagnosia as the initial sign of degenerative dementia. Mayo Clin Proc. 1993 Oct; 68 (10):955-64
     View PubMed
258. Caselli RJ, Scheithauer BW, O'Duffy JD, Peterson GC, Westmoreland BF, Davenport PA. Chronic inflammatory meningoencephalitis should not be mistaken for Alzheimer's disease. Mayo Clin Proc. 1993 Sep; 68 (9):846-53
     View PubMed
259. Caselli RJ. Ventrolateral and dorsomedial somatosensory association cortex damage produces distinct somesthetic syndromes in humans. Neurology. 1993 Apr; 43 (4):762-71
     View PubMed
260. Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, Okazaki H, Kokmen E, Iverson R, Dinapoli RP, Graff-Radford NR. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993 Feb; 33 (2):200-7
     View PubMed
261. Caselli RJ, Jack CR Jr, Petersen RC, Wahner HW, Yanagihara T. Asymmetric cortical degenerative syndromes: clinical and radiologic correlations. Neurology. 1992 Aug; 42 (8):1462-8
     View PubMed
262. Caselli RJ, Jack CR Jr. Asymmetric cortical degeneration syndromes. A proposed clinical classification. Arch Neurol. 1992 Jul; 49 (7):770-80
     View PubMed
263. Caselli RJ, Ivnik RJ, Duffy JR. Associative anomia: dissociating words and their definitions. Mayo Clin Proc. 1991 Aug; 66 (8):783-91
     View PubMed
264. Caselli RJ, Scheithauer BW, Bowles CA, Trenerry MR, Meyer FB, Smigielski JS, Rodriguez M. The treatable dementia of Sjogren's syndrome. Ann Neurol. 1991 Jul; 30 (1):98-101
     View PubMed
265. Caselli RJ. Bilateral impairment of somesthetically mediated object recognition in humans. Mayo Clin Proc. 1991 Apr; 66 (4):357-64
     View PubMed
266. Caselli RJ. Rediscovering tactile agnosia. Mayo Clin Proc. 1991 Feb; 66 (2):129-42
     View PubMed
267. Caselli RJ. Neurovascular complications of giant cell (temporal) arteritis. Sang Thromb Vaiss. 1991; 3:19-24.
     
268. Caselli RJ, Graff-Radford NR, Rezai K. Thalamocortical diaschisis: a single photon emission tomography (SPET) study of cortical perfusion changes following focal thalamic infarctions. Neuropsychiatry Neuropsychol Behav Neurol. 1991; 4:193-214.
     
269. Caselli RJ. Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia. Neurology. 1990 May; 40 (5):753-5
     View PubMed
270. Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988 May; 38 (5):685-9
     View PubMed
271. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988 Mar; 38 (3):352-9
     View PubMed